These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16827885)

  • 1. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
    Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
    Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual inclusions in plasmacytoid cells. Their occurrence in a patient with Waldenström's macroglobulinemia.
    Ricci A; Monahan RA; Paradise C; Robinson S; Dvorak AM
    Arch Pathol Lab Med; 1982 Sep; 106(9):452-7. PubMed ID: 6287959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
    Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
    Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM myeloma: a report of four cases.
    Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
    Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
    Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
    Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM myeloma. Apropos of a case].
    Heron JF; Guaydier G; Loyau G; Laniece M; Mandart JC; Borel B; L'Hirondel JL; Dumas M; Foucault JP
    Sem Hop; 1976 Dec; 52(44):2549-52. PubMed ID: 188198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypercalcemia complicating Waldenström's disease: a manifestation of Richter's syndrome].
    Casassus P; Vannetzel JM; Tricot G; D'Agay MF; Lortholary P; Desrues J; Pariente P
    Ann Med Interne (Paris); 1983; 134(2):130-3. PubMed ID: 6410954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
    Wang E; Kulbacki E; Stoecker M
    Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron microscopic observation of inclusion bodies in plasma cells of multiple myeloma and Waldenström's macroglobulinemia.
    Oikawa K
    Tohoku J Exp Med; 1975 Nov; 117(3):257-81. PubMed ID: 173043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
    Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
    Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
    Donovan KA; Lacy MQ; Gertz MA; Lust JA
    Leukemia; 2002 Mar; 16(3):382-5. PubMed ID: 11896542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous Waldenström's macroglobulinemia].
    Mantoux F; Castanet J; Perrin C; Fuzibet JG; Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):53-5. PubMed ID: 11937931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
    Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ
    Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in Waldenstrom's macroglobulinemia.
    Rajkumar SV; Hayman S; Greipp PR
    Semin Oncol; 2003 Apr; 30(2):262-4. PubMed ID: 12720149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphologic manifestations of Waldenström's disease].
    Diebold J; Reynes M; Kalifat R; Tricot G
    Sem Hop; 1975 Dec; 51(48):2927-34. PubMed ID: 175504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
    Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
    Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.